“Collagen market set to grow to $6bn by 2024” says new Visiongain report

08 April 2019
Pharma

Visiongain has launched a new pharma report Collagen Market Forecast 2019-2029: Revenue Prospects for Source, Product, and Application.

Currently, collagen has become in demand ingredient towards healthy foods development. Collagen productions in the body decline with age and bad diet. As collagen injection is not a preference to most people, the best way to gain collagen is through diet. Consequently, collagen has been blended together in a variety of foods and beverages products. Furthermore, it has been applied as protein dietary supplements, carriers in the meat processing, edible film and coatings of products, and food additive to enhance products’ quality.

The lead analyst of the report commented "Demand for premium grade collagen for surgical procedures, wound dressing, and drug delivery mechanisms is expected to drive the market within the forecast period. Marine collagen is expected to grow at a fast pace in the forecast period. Marine collagens are regarded as superior collagens as they are absorbed much more efficiently into the body. The market in the Asia Pacific is expected to register comparatively faster growth in terms of revenue over the next 10 years and this is attributed to increasing demand for beauty products and health supplements in the region."

Leading companies featured in the report include Advanced BioMatrix, Inc., Collagen Matrix, Collagen Solution Plc, Cologenesis HealthCare Pvt. Ltd., CONNOILS LLC, Croda International Plc., JBS S.A., Koninklijke DSM N.V., and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever